Impact of COVID-19 Outbreak on Coronary Intervention Drug Eluting Stent, Global Market Research Report 2020

Published On: May 2020

Format: PDF

Publisher: QY Research

Pages: 131

Report ID: 161415

The research report has incorporated the analysis of different factors that augment the market’s growth. It constitutes trends, restraints, and drivers that transform the market in either a positive or negative manner. This section also provides the scope of different segments and applications that can potentially influence the market in the future. The detailed information is based on current trends and historic milestones. This section also provides an analysis of the volume of production about the global market and also about each type from 2015 to 2026. This section mentions the volume of production by region from 2015 to 2026. Pricing analysis is included in the report according to each type from the year 2015 to 2026, manufacturer from 2015 to 2020, region from 2015 to 2020, and global price from 2015 to 2026.
A thorough evaluation of the restrains included in the report portrays the contrast to drivers and gives room for strategic planning. Factors that overshadow the market growth are pivotal as they can be understood to devise different bends for getting hold of the lucrative opportunities that are present in the ever-growing market. Additionally, insights into market expert’s opinions have been taken to understand the market better.

Market Segment Analysis
The research report includes specific segments by Type and by Application. Each type provides information about the production during the forecast period of 2015 to 2026. Application segment also provides consumption during the forecast period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Below 40 µm
40 µm- 65 µm
Above 65 µm

Segment by Application
Hospital
Clinic
Others

Global Coronary Intervention Drug Eluting Stent Market: Regional Analysis
The report offers in-depth assessment of the growth and other aspects of the Coronary Intervention Drug Eluting Stent market in important regions, including the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, Taiwan, Southeast Asia, Mexico, and Brazil, etc. Key regions covered in the report are North America, Europe, Asia-Pacific and Latin America.
The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue, production, and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2015 to 2026. These analyses will help the reader to understand the potential worth of investment in a particular region.

Global Coronary Intervention Drug Eluting Stent Market: Competitive Landscape
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and production by manufacturers during the forecast period of 2015 to 2019.
The major players in the market include Synlas GmbH, YILSON, BrosMed Medical, SCITECH Medical, Wellinq, Degania Silicone, Alvimedica, Interventional Medical Device Solutions, Comed BV, iVascular, LEPU Medical, Eurocor Tech GmbH, OrbusNeich, Endocor GmbH, Meril Life Sciences, Acrostak, Boston Scientific Corporation, B. Braun, Biotronik, Abbott, MicroPort Medical Group, Philips, Terumo Corporation, etc.

1 Coronary Intervention Drug Eluting Stent Market Overview
1.1 Product Overview and Scope of Coronary Intervention Drug Eluting Stent
1.2 Covid-19 Implications on Coronary Intervention Drug Eluting Stent Segment by Type
1.2.1 Global Coronary Intervention Drug Eluting Stent Production Growth Rate Comparison by Type 2020 VS 2026
1.2.2 Below 40 µm
1.2.3 40 µm- 65 µm
1.2.4 Above 65 µm
1.3 Covid-19 Implications on Coronary Intervention Drug Eluting Stent Segment by Application
1.3.1 Coronary Intervention Drug Eluting Stent Consumption Comparison by Application: 2020 VS 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Covid-19 Implications on Global Coronary Intervention Drug Eluting Stent Market by Region
1.4.1 Global Coronary Intervention Drug Eluting Stent Market Size Estimates and Forecasts by Region: 2020 VS 2026
1.4.2 North America Estimates and Forecasts (2015-2026)
1.4.3 Europe Estimates and Forecasts (2015-2026)
1.4.4 China Estimates and Forecasts (2015-2026)
1.4.5 Japan Estimates and Forecasts (2015-2026)
1.5 Covid-19 Implications on Global Coronary Intervention Drug Eluting Stent Growth Prospects
1.5.1 Global Coronary Intervention Drug Eluting Stent Revenue Estimates and Forecasts (2015-2026)
1.5.2 Global Coronary Intervention Drug Eluting Stent Production Capacity Estimates and Forecasts (2015-2026)
1.5.3 Global Coronary Intervention Drug Eluting Stent Production Estimates and Forecasts (2015-2026)
1.6 Coronavirus Disease 2019 (Covid-19): Coronary Intervention Drug Eluting Stent Industry Impact
1.6.1 How the Covid-19 is Affecting the Coronary Intervention Drug Eluting Stent Industry
1.6.1.1 Coronary Intervention Drug Eluting Stent Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Coronary Intervention Drug Eluting Stent Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Coronary Intervention Drug Eluting Stent Players to Combat Covid-19 Impact

2 Covid-19 Implications on Market Competition by Manufacturers
2.1 Global Coronary Intervention Drug Eluting Stent Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Coronary Intervention Drug Eluting Stent Revenue Share by Manufacturers (2015-2020)
2.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.4 Global Coronary Intervention Drug Eluting Stent Average Price by Manufacturers (2015-2020)
2.5 Manufacturers Coronary Intervention Drug Eluting Stent Production Sites, Area Served, Product Types
2.6 Coronary Intervention Drug Eluting Stent Market Competitive Situation and Trends
2.6.1 Coronary Intervention Drug Eluting Stent Market Concentration Rate
2.6.2 Global Top 3 and Top 5 Players Market Share by Revenue
2.6.3 Mergers & Acquisitions, Expansion

3 Covid-19 Implications on Production and Capacity by Region
3.1 Global Production Capacity of Coronary Intervention Drug Eluting Stent Market Share by Regions (2015-2020)
3.2 Global Coronary Intervention Drug Eluting Stent Revenue Market Share by Regions (2015-2020)
3.3 Global Coronary Intervention Drug Eluting Stent Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 North America Coronary Intervention Drug Eluting Stent Production
3.4.1 North America Coronary Intervention Drug Eluting Stent Production Growth Rate (2015-2020)
3.4.2 North America Coronary Intervention Drug Eluting Stent Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Coronary Intervention Drug Eluting Stent Production
3.5.1 Europe Coronary Intervention Drug Eluting Stent Production Growth Rate (2015-2020)
3.5.2 Europe Coronary Intervention Drug Eluting Stent Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 China Coronary Intervention Drug Eluting Stent Production
3.6.1 China Coronary Intervention Drug Eluting Stent Production Growth Rate (2015-2020)
3.6.2 China Coronary Intervention Drug Eluting Stent Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Japan Coronary Intervention Drug Eluting Stent Production
3.7.1 Japan Coronary Intervention Drug Eluting Stent Production Growth Rate (2015-2020)
3.7.2 Japan Coronary Intervention Drug Eluting Stent Production Capacity, Revenue, Price and Gross Margin (2015-2020)

4 Covid-19 Implications on Global Coronary Intervention Drug Eluting Stent Consumption by Regions
4.1 Global Coronary Intervention Drug Eluting Stent Consumption by Regions
4.1.1 Global Coronary Intervention Drug Eluting Stent Consumption by Region
4.1.2 Global Coronary Intervention Drug Eluting Stent Consumption Market Share by Region
4.2 North America
4.2.1 North America Coronary Intervention Drug Eluting Stent Consumption by Countries
4.2.2 U.S.
4.2.3 Canada
4.3 Europe
4.3.1 Europe Coronary Intervention Drug Eluting Stent Consumption by Countries
4.3.2 Germany
4.3.3 France
4.3.4 U.K.
4.3.5 Italy
4.3.6 Russia
4.4 Asia Pacific
4.4.1 Asia Pacific Coronary Intervention Drug Eluting Stent Consumption by Region
4.4.2 China
4.4.3 Japan
4.4.4 South Korea
4.4.5 Taiwan
4.4.6 Southeast Asia
4.4.7 India
4.4.8 Australia
4.5 Latin America
4.5.1 Latin America Coronary Intervention Drug Eluting Stent Consumption by Countries
4.5.2 Mexico
4.5.3 Brazil

5 Covid-19 Implications on Coronary Intervention Drug Eluting Stent Production, Revenue, Price Trend by Type
5.1 Global Coronary Intervention Drug Eluting Stent Production Market Share by Type (2015-2020)
5.2 Global Coronary Intervention Drug Eluting Stent Revenue Market Share by Type (2015-2020)
5.3 Global Coronary Intervention Drug Eluting Stent Price by Type (2015-2020)
5.4 Global Coronary Intervention Drug Eluting Stent Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

6 Covid-19 Implications on Global Coronary Intervention Drug Eluting Stent Market Analysis by Application
6.1 Global Coronary Intervention Drug Eluting Stent Consumption Market Share by Application (2015-2020)
6.2 Global Coronary Intervention Drug Eluting Stent Consumption Growth Rate by Application (2015-2020)

7 Covid-19 Implications on Company Profiles and Key Figures in Coronary Intervention Drug Eluting Stent Business
7.1 Synlas GmbH
7.1.1 Synlas GmbH Coronary Intervention Drug Eluting Stent Production Sites and Area Served
7.1.2 Synlas GmbH Coronary Intervention Drug Eluting Stent Product Introduction, Application and Specification
7.1.3 Synlas GmbH Coronary Intervention Drug Eluting Stent Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.1.4 Synlas GmbH Main Business and Markets Served
7.2 YILSON
7.2.1 YILSON Coronary Intervention Drug Eluting Stent Production Sites and Area Served
7.2.2 YILSON Coronary Intervention Drug Eluting Stent Product Introduction, Application and Specification
7.2.3 YILSON Coronary Intervention Drug Eluting Stent Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.2.4 YILSON Main Business and Markets Served
7.3 BrosMed Medical
7.3.1 BrosMed Medical Coronary Intervention Drug Eluting Stent Production Sites and Area Served
7.3.2 BrosMed Medical Coronary Intervention Drug Eluting Stent Product Introduction, Application and Specification
7.3.3 BrosMed Medical Coronary Intervention Drug Eluting Stent Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.3.4 BrosMed Medical Main Business and Markets Served
7.4 SCITECH Medical
7.4.1 SCITECH Medical Coronary Intervention Drug Eluting Stent Production Sites and Area Served
7.4.2 SCITECH Medical Coronary Intervention Drug Eluting Stent Product Introduction, Application and Specification
7.4.3 SCITECH Medical Coronary Intervention Drug Eluting Stent Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.4.4 SCITECH Medical Main Business and Markets Served
7.5 Wellinq
7.5.1 Wellinq Coronary Intervention Drug Eluting Stent Production Sites and Area Served
7.5.2 Wellinq Coronary Intervention Drug Eluting Stent Product Introduction, Application and Specification
7.5.3 Wellinq Coronary Intervention Drug Eluting Stent Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.5.4 Wellinq Main Business and Markets Served
7.6 Degania Silicone
7.6.1 Degania Silicone Coronary Intervention Drug Eluting Stent Production Sites and Area Served
7.6.2 Degania Silicone Coronary Intervention Drug Eluting Stent Product Introduction, Application and Specification
7.6.3 Degania Silicone Coronary Intervention Drug Eluting Stent Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.6.4 Degania Silicone Main Business and Markets Served
7.7 Alvimedica
7.7.1 Alvimedica Coronary Intervention Drug Eluting Stent Production Sites and Area Served
7.7.2 Alvimedica Coronary Intervention Drug Eluting Stent Product Introduction, Application and Specification
7.7.3 Alvimedica Coronary Intervention Drug Eluting Stent Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.7.4 Alvimedica Main Business and Markets Served
7.8 Interventional Medical Device Solutions
7.8.1 Interventional Medical Device Solutions Coronary Intervention Drug Eluting Stent Production Sites and Area Served
7.8.2 Interventional Medical Device Solutions Coronary Intervention Drug Eluting Stent Product Introduction, Application and Specification
7.8.3 Interventional Medical Device Solutions Coronary Intervention Drug Eluting Stent Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.8.4 Interventional Medical Device Solutions Main Business and Markets Served
7.9 Comed BV
7.9.1 Comed BV Coronary Intervention Drug Eluting Stent Production Sites and Area Served
7.9.2 Comed BV Coronary Intervention Drug Eluting Stent Product Introduction, Application and Specification
7.9.3 Comed BV Coronary Intervention Drug Eluting Stent Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.9.4 Comed BV Main Business and Markets Served
7.10 iVascular
7.10.1 iVascular Coronary Intervention Drug Eluting Stent Production Sites and Area Served
7.10.2 iVascular Coronary Intervention Drug Eluting Stent Product Introduction, Application and Specification
7.10.3 iVascular Coronary Intervention Drug Eluting Stent Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.10.4 iVascular Main Business and Markets Served
7.11 LEPU Medical
7.11.1 LEPU Medical Coronary Intervention Drug Eluting Stent Production Sites and Area Served
7.11.2 LEPU Medical Coronary Intervention Drug Eluting Stent Product Introduction, Application and Specification
7.11.3 LEPU Medical Coronary Intervention Drug Eluting Stent Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.11.4 LEPU Medical Main Business and Markets Served
7.12 Eurocor Tech GmbH
7.12.1 Eurocor Tech GmbH Coronary Intervention Drug Eluting Stent Production Sites and Area Served
7.12.2 Eurocor Tech GmbH Coronary Intervention Drug Eluting Stent Product Introduction, Application and Specification
7.12.3 Eurocor Tech GmbH Coronary Intervention Drug Eluting Stent Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.12.4 Eurocor Tech GmbH Main Business and Markets Served
7.13 OrbusNeich
7.13.1 OrbusNeich Coronary Intervention Drug Eluting Stent Production Sites and Area Served
7.13.2 OrbusNeich Coronary Intervention Drug Eluting Stent Product Introduction, Application and Specification
7.13.3 OrbusNeich Coronary Intervention Drug Eluting Stent Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.13.4 OrbusNeich Main Business and Markets Served
7.14 Endocor GmbH
7.14.1 Endocor GmbH Coronary Intervention Drug Eluting Stent Production Sites and Area Served
7.14.2 Endocor GmbH Coronary Intervention Drug Eluting Stent Product Introduction, Application and Specification
7.14.3 Endocor GmbH Coronary Intervention Drug Eluting Stent Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.14.4 Endocor GmbH Main Business and Markets Served
7.15 Meril Life Sciences
7.15.1 Meril Life Sciences Coronary Intervention Drug Eluting Stent Production Sites and Area Served
7.15.2 Meril Life Sciences Coronary Intervention Drug Eluting Stent Product Introduction, Application and Specification
7.15.3 Meril Life Sciences Coronary Intervention Drug Eluting Stent Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.15.4 Meril Life Sciences Main Business and Markets Served
7.16 Acrostak
7.16.1 Acrostak Coronary Intervention Drug Eluting Stent Production Sites and Area Served
7.16.2 Acrostak Coronary Intervention Drug Eluting Stent Product Introduction, Application and Specification
7.16.3 Acrostak Coronary Intervention Drug Eluting Stent Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.16.4 Acrostak Main Business and Markets Served
7.17 Boston Scientific Corporation
7.17.1 Boston Scientific Corporation Coronary Intervention Drug Eluting Stent Production Sites and Area Served
7.17.2 Boston Scientific Corporation Coronary Intervention Drug Eluting Stent Product Introduction, Application and Specification
7.17.3 Boston Scientific Corporation Coronary Intervention Drug Eluting Stent Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.17.4 Boston Scientific Corporation Main Business and Markets Served
7.18 B. Braun
7.18.1 B. Braun Coronary Intervention Drug Eluting Stent Production Sites and Area Served
7.18.2 B. Braun Coronary Intervention Drug Eluting Stent Product Introduction, Application and Specification
7.18.3 B. Braun Coronary Intervention Drug Eluting Stent Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.18.4 B. Braun Main Business and Markets Served
7.19 Biotronik
7.19.1 Biotronik Coronary Intervention Drug Eluting Stent Production Sites and Area Served
7.19.2 Biotronik Coronary Intervention Drug Eluting Stent Product Introduction, Application and Specification
7.19.3 Biotronik Coronary Intervention Drug Eluting Stent Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.19.4 Biotronik Main Business and Markets Served
7.20 Abbott
7.20.1 Abbott Coronary Intervention Drug Eluting Stent Production Sites and Area Served
7.20.2 Abbott Coronary Intervention Drug Eluting Stent Product Introduction, Application and Specification
7.20.3 Abbott Coronary Intervention Drug Eluting Stent Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.20.4 Abbott Main Business and Markets Served
7.21 MicroPort Medical Group
7.21.1 MicroPort Medical Group Coronary Intervention Drug Eluting Stent Production Sites and Area Served
7.21.2 MicroPort Medical Group Coronary Intervention Drug Eluting Stent Product Introduction, Application and Specification
7.21.3 MicroPort Medical Group Coronary Intervention Drug Eluting Stent Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.21.4 MicroPort Medical Group Main Business and Markets Served
7.22 Philips
7.22.1 Philips Coronary Intervention Drug Eluting Stent Production Sites and Area Served
7.22.2 Philips Coronary Intervention Drug Eluting Stent Product Introduction, Application and Specification
7.22.3 Philips Coronary Intervention Drug Eluting Stent Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.22.4 Philips Main Business and Markets Served
7.23 Terumo Corporation
7.23.1 Terumo Corporation Coronary Intervention Drug Eluting Stent Production Sites and Area Served
7.23.2 Terumo Corporation Coronary Intervention Drug Eluting Stent Product Introduction, Application and Specification
7.23.3 Terumo Corporation Coronary Intervention Drug Eluting Stent Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.23.4 Terumo Corporation Main Business and Markets Served

8 Coronary Intervention Drug Eluting Stent Manufacturing Cost Analysis
8.1 Coronary Intervention Drug Eluting Stent Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Raw Materials Price Trend
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Coronary Intervention Drug Eluting Stent
8.4 Coronary Intervention Drug Eluting Stent Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Coronary Intervention Drug Eluting Stent Distributors List
9.3 Coronary Intervention Drug Eluting Stent Customers

10 Market Dynamics
10.1 Market Trends
10.2 Opportunities and Drivers
10.3 Challenges
10.4 Porter's Five Forces Analysis

11 Production and Supply Forecast
11.1 Global Forecasted Production of Coronary Intervention Drug Eluting Stent (2021-2026)
11.2 Global Forecasted Revenue of Coronary Intervention Drug Eluting Stent (2021-2026)
11.3 Global Forecasted Price of Coronary Intervention Drug Eluting Stent (2021-2026)
11.4 Global Coronary Intervention Drug Eluting Stent Production Forecast by Regions (2021-2026)
11.4.1 North America Coronary Intervention Drug Eluting Stent Production, Revenue Forecast (2021-2026)
11.4.2 Europe Coronary Intervention Drug Eluting Stent Production, Revenue Forecast (2021-2026)
11.4.3 China Coronary Intervention Drug Eluting Stent Production, Revenue Forecast (2021-2026)
11.4.4 Japan Coronary Intervention Drug Eluting Stent Production, Revenue Forecast (2021-2026)

12 Consumption and Demand Forecast
12.1 Global Forecasted and Consumption Demand Analysis of Coronary Intervention Drug Eluting Stent
12.2 North America Forecasted Consumption of Coronary Intervention Drug Eluting Stent by Country
12.3 Europe Market Forecasted Consumption of Coronary Intervention Drug Eluting Stent by Country
12.4 Asia Pacific Market Forecasted Consumption of Coronary Intervention Drug Eluting Stent by Regions
12.5 Latin America Forecasted Consumption of Coronary Intervention Drug Eluting Stent
13 Forecast by Type and by Application (2021-2026)
13.1 Global Production, Revenue and Price Forecast by Type (2021-2026)
13.1.1 Global Forecasted Production of Coronary Intervention Drug Eluting Stent by Type (2021-2026)
13.1.2 Global Forecasted Revenue of Coronary Intervention Drug Eluting Stent by Type (2021-2026)
13.1.2 Global Forecasted Price of Coronary Intervention Drug Eluting Stent by Type (2021-2026)
13.2 Global Forecasted Consumption of Coronary Intervention Drug Eluting Stent by Application (2021-2026)
14 Research Finding and Conclusion

15 Methodology and Data Source
15.1 Methodology/Research Approach
15.1.1 Research Programs/Design
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 Data Source
15.2.1 Secondary Sources
15.2.2 Primary Sources
15.3 Author List
15.4 Disclaimer